CN Patent

CN112557533A — 一种恩格列净的分析方法

Assigned to Beijing Kang Lisheng Pharmaceutical Technology Development Co ltd · Expires 2021-03-26 · 5y expired

What this patent protects

本发明涉及一种恩格列净的分析方法，取恩格列净产品的任意一种适量，精密称定，加甲醇溶解并稀释制成供试品溶液；供试液溶液采用HPLC的方法进行分析，恩格列净产品包括：恩格列净原料粗品、恩格列净原料、恩格列净原料药、恩格列净对照品、恩格列净标准品、恩格列净晶型、恩格列净C晶型、恩格列净原料中间体、含有恩格列净的组合物、恩格列净的制剂、恩格列净的片剂、恩格列净的缓释片剂。

USPTO Abstract

本发明涉及一种恩格列净的分析方法，取恩格列净产品的任意一种适量，精密称定，加甲醇溶解并稀释制成供试品溶液；供试液溶液采用HPLC的方法进行分析，恩格列净产品包括：恩格列净原料粗品、恩格列净原料、恩格列净原料药、恩格列净对照品、恩格列净标准品、恩格列净晶型、恩格列净C晶型、恩格列净原料中间体、含有恩格列净的组合物、恩格列净的制剂、恩格列净的片剂、恩格列净的缓释片剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN112557533A
Jurisdiction
CN
Classification
—
Expires
2021-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kang Lisheng Pharmaceutical Technology Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.